Evidence map›Paper›PMID 32641832›Full record

ArticleNature2020

Glucose metabolism links astroglial mitochondria to cannabinoid effects.

Daniel Jimenez-Blasco, Arnau Busquets-Garcia, Etienne Hebert-Chatelain, Roman Serrat, Carlos Vicente-Gutierrez, Christina Ioannidou, Paula Gómez-Sotres, Irene Lopez-Fabuel, Monica Resch-Beusher, Eva Resel and 24 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Nature, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 140 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
140citing papers in PubMed, 1 pooled it
27.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

140 citing papers in PubMed, 1 synthesis or guideline pooled it, 254 citations in OpenAlex.

  1. Pooled it
  2. Does cannabidiol reduce the adverse effects of cannabis in schizophrenia? A randomised, double-blind, cross-over trial.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Trial
  3. Trial
  4. The endocannabinoid system and the ageing brain.Nature reviews. Neuroscience · 2026
    Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. A transient mitochondrial switch underlies long lasting effects of adolescent cannabis.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  10. Review
  11. Article
  12. Astrocytic GPR55 receptors promote glycolysis.Journal of cannabis research · 2026
    Article
  13. Article
  14. Article
  15. Astrocyte CBJournal of neuroinflammation · 2026
    Article
  16. Genetic Tools in Rodents to Study Cannabinoid Functions.Current topics in behavioral neurosciences · 2026
    Review
  17. Article
  18. Review
  19. Review
  20. Article

80 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

34 authors at 8 institutions in 6 countries.

Daniel Jimenez-Blasco *Institute of Functional Biology and Genomics, University of Salamanca, CSIC, Salamanca, Spain.ORCID http://orcid.org/0000-0002-1384-1832
Arnau Busquets-Garcia *INSERM, U1215 NeuroCentre Magendie, Bordeaux, France.ORCID http://orcid.org/0000-0002-7100-8873
Etienne Hebert-Chatelain *Canada Research Chair in Mitochondrial Signaling and Physiopathology, Université de Moncton, Moncton, New Brunswick, Canada.
Roman SerratINSERM, U1215 NeuroCentre Magendie, Bordeaux, France.
Carlos Vicente-GutierrezInstitute of Functional Biology and Genomics, University of Salamanca, CSIC, Salamanca, Spain.ORCID http://orcid.org/0000-0002-6481-595X
Christina IoannidouINSERM, U1215 NeuroCentre Magendie, Bordeaux, France.ORCID http://orcid.org/0000-0003-2726-0403
Paula Gómez-SotresINSERM, U1215 NeuroCentre Magendie, Bordeaux, France.
Irene Lopez-FabuelInstitute of Functional Biology and Genomics, University of Salamanca, CSIC, Salamanca, Spain.ORCID http://orcid.org/0000-0002-3049-748X
Monica Resch-BeusherInstitute of Functional Biology and Genomics, University of Salamanca, CSIC, Salamanca, Spain.
Eva ReselInstituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Instituto Universitario de Investigación Neuroquímica (IUIN) and Department of Biochemistry and Molecular Biology, Complutense University, Madrid, Spain.
Dorian ArnouilINSERM, U1215 NeuroCentre Magendie, Bordeaux, France.
Dave SaraswatINSERM, U1215 NeuroCentre Magendie, Bordeaux, France.
Marjorie VarilhINSERM, U1215 NeuroCentre Magendie, Bordeaux, France.
Astrid CannichINSERM, U1215 NeuroCentre Magendie, Bordeaux, France.
Francisca Julio-KalajzicINSERM, U1215 NeuroCentre Magendie, Bordeaux, France.
Itziar Bonilla-Del RíoDepartment of Neurosciences, University of the Basque Country (UPV/EHU), Leioa, Spain.
Angeles AlmeidaInstitute of Functional Biology and Genomics, University of Salamanca, CSIC, Salamanca, Spain.
Nagore PuenteDepartment of Neurosciences, University of the Basque Country (UPV/EHU), Leioa, Spain.
Svein AchicallendeDepartment of Neurosciences, University of the Basque Country (UPV/EHU), Leioa, Spain.ORCID http://orcid.org/0000-0002-9245-9761
Maria-Luz Lopez-RodriguezDepartment of Organic Chemistry, Complutense University, Madrid, Spain.
Charlotte JolléDepartment of Physiology, University of Lausanne, Lausanne, Switzerland.
Nicole DéglonDepartment of Clinical Neurosciences, Laboratory of Cellular and Molecular Neurotherapies (LCMN), University of Lausanne, Lausanne, Switzerland.
Luc PellerinDepartment of Physiology, University of Lausanne, Lausanne, Switzerland.
Charlène JosephineUniversité Paris-Saclay, CEA, CNRS, MIRCen, Laboratoire des Maladies Neurodégénératives, Fontenay-aux-Roses, France.
Gilles BonventoUniversité Paris-Saclay, CEA, CNRS, MIRCen, Laboratoire des Maladies Neurodégénératives, Fontenay-aux-Roses, France.ORCID http://orcid.org/0000-0002-2886-4228
Aude PanatierINSERM, U1215 NeuroCentre Magendie, Bordeaux, France.ORCID http://orcid.org/0000-0002-6107-4463
Beat LutzInstitute of Physiological Chemistry, University Medical Center, Mainz, Germany.
Pier-Vincenzo PiazzaINSERM, U1215 NeuroCentre Magendie, Bordeaux, France.
Manuel GuzmánInstituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Instituto Universitario de Investigación Neuroquímica (IUIN) and Department of Biochemistry and Molecular Biology, Complutense University, Madrid, Spain.
Luigi BellocchioINSERM, U1215 NeuroCentre Magendie, Bordeaux, France.
Anne-Karine Bouzier-SoreCentre de Résonance Magnétique des Systèmes Biologiques UMR 5536, CNRS-University of Bordeaux, Bordeaux, France.
Pedro GrandesDepartment of Neurosciences, University of the Basque Country (UPV/EHU), Leioa, Spain.
Juan P BolañosInstitute of Functional Biology and Genomics, University of Salamanca, CSIC, Salamanca, Spain. jbolanos@usal.es.ORCID http://orcid.org/0000-0002-3949-6862
Giovanni MarsicanoINSERM, U1215 NeuroCentre Magendie, Bordeaux, France. giovanni.marsicano@inserm.fr.ORCID http://orcid.org/0000-0003-3804-1951
Université de Bordeaux · FRUniversidad de Salamanca · ESCentre National de la Recherche Scientifique · FRUniversity of the Basque Country · ESUniversidad Complutense de Madrid · ESUniversity of Lausanne · CHJohannes Gutenberg University Mainz · DEUniversité de Moncton · CA

Funding

European Research CouncilNIH HHS 1R21DA037678-01
6 · The paper itself

Abstract

Astrocytes take up glucose from the bloodstream to provide energy to the brain, thereby allowing neuronal activity and behavioural responses

Indexed as

Energy MetabolismAnimalsAstrocytesCannabinoid Receptor AgonistsCells, CulturedDronabinolElectron Transport Complex IGlucoseGlycolysisHumansHypoxia-Inducible Factor 1Lactic AcidMaleMiceMitochondriaMitochondrial MembranesCannabinoid Receptor AgonistsDronabinolElectron Transport Complex IGlucoseHypoxia-Inducible Factor 1Lactic AcidNDUFS4 protein, humanReactive Oxygen SpeciesReceptor, Cannabinoid, CB1

Identifiers

PMID32641832
OpenAlexW3041337213

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.